BioScience Managers
As an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare, we have a team with the ambition and experience to deliver impressive investment returns.
Latest news
- Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update 12 August 2022
- Humanetix – How prepared are you for AN-ACC? 11 August 2022
- CalciMedica Announces Publication of Preclinical Data in EMBO Molecular Medicine Supporting the Development of CRAC Channel Inhibitors for Inflammatory Bowel Disease (IBD) 10 August 2022